159 related articles for article (PubMed ID: 1310879)
1. Heparin-associated thrombocytopenia: successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins.
Greinacher A; Drost W; Michels I; Leitl J; Gottsmann M; Kohl HJ; Glaser M; Mueller-Eckhardt C
Ann Hematol; 1992 Jan; 64(1):40-2. PubMed ID: 1310879
[TBL] [Abstract][Full Text] [Related]
2. [Heparin-associated thrombocytopenia: successful therapy of patients after prospective selection of a compatible heparinoid with the heparin-induced platelet activation test].
Greinacher A; Michels I; Mueller-Eckhardt C
Beitr Infusionsther; 1992; 30():408-12. PubMed ID: 1284747
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).
Greinacher A; Eckhardt T; Mussmann J; Mueller-Eckhardt C
Thromb Res; 1993 Jul; 71(2):123-6. PubMed ID: 7689764
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.
Keeling DM; Richards EM; Baglin TP
Br J Haematol; 1994 Feb; 86(2):425-6. PubMed ID: 7515270
[TBL] [Abstract][Full Text] [Related]
5. Heparin-associated thrombocytopenia: the antibody is not heparin specific.
Greinacher A; Michels I; Mueller-Eckhardt C
Thromb Haemost; 1992 May; 67(5):545-9. PubMed ID: 1325681
[TBL] [Abstract][Full Text] [Related]
6. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
Muhm M; Claeys L; Huk I; Koppensteiner R; Kyrle PA; Minar E; Stümpflen A; Ehringer H; Polterauer P
Wien Klin Wochenschr; 1997 Feb; 109(4):128-31. PubMed ID: 9076930
[TBL] [Abstract][Full Text] [Related]
8. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
Kikta MJ; Keller MP; Humphrey PW; Silver D
Surgery; 1993 Oct; 114(4):705-10. PubMed ID: 7692613
[TBL] [Abstract][Full Text] [Related]
9. The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.
Rowlings PA; Mansberg R; Rozenberg MC; Evans S; Murray B
Aust N Z J Med; 1991 Feb; 21(1):52-4. PubMed ID: 1709804
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia.
Vun CM; Evans S; Chong BH
Thromb Res; 1996 Mar; 81(5):525-32. PubMed ID: 8907311
[TBL] [Abstract][Full Text] [Related]
11. Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.
Harenberg J; Zimmermann R; Schwarz F; Kübler W
Lancet; 1983 Apr; 1(8331):986-7. PubMed ID: 6132291
[No Abstract] [Full Text] [Related]
12. [Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
Herzog S; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):164-6. PubMed ID: 7665065
[TBL] [Abstract][Full Text] [Related]
13. Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models.
Meuleman DG
Semin Thromb Hemost; 1989 Oct; 15(4):370-2. PubMed ID: 2479103
[TBL] [Abstract][Full Text] [Related]
14. Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
Greinacher A; Philippen KH; Kemkes-Matthes B; Möckl M; Mueller-Eckhardt C; Schaefer K
Nephrol Dial Transplant; 1993; 8(10):1176-7. PubMed ID: 7505906
[No Abstract] [Full Text] [Related]
15. Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.
Chong BH; Ismail F; Cade J; Gallus AS; Gordon S; Chesterman CN
Blood; 1989 May; 73(6):1592-6. PubMed ID: 2713496
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.
van Besien K; Hoffman R; Golichowski A
Thromb Res; 1991 Apr; 62(1-2):23-9. PubMed ID: 1712988
[TBL] [Abstract][Full Text] [Related]
17. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia.
Greinacher A; Michels I; Kiefel V; Mueller-Eckhardt C
Thromb Haemost; 1991 Dec; 66(6):734-6. PubMed ID: 1796420
[TBL] [Abstract][Full Text] [Related]
18. [Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].
Mahul P; Raynaud J; Favre JP; Jospé R; Décousus H; Auboyer C
Ann Fr Anesth Reanim; 1995; 14(1):29-32. PubMed ID: 7677282
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparins and heparinoids.
Eikelboom JW; Hankey GJ
Med J Aust; 2002 Oct; 177(7):379-83. PubMed ID: 12358583
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).
Ramakrishna R; Manoharan A; Kwan YL; Kyle PW
Br J Haematol; 1995 Nov; 91(3):736-8. PubMed ID: 8555084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]